Skip to main content

Advertisement

ADVERTISEMENT

Videos

CCM Video Thumbnail
Videos
09/28/2023
In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...
In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...
In this Cancer Care Business...
09/28/2023
Cancer Care Business Exchange

Advertisement

The Hunt for Value in Value-Based Care
Videos
09/18/2023
Frederick Schnell, MD, FACP, Community Oncology Alliance, previews his session at CPC + CBEx in October on market dynamics that are affecting the implementation of value-based cancer care.
Frederick Schnell, MD, FACP, Community Oncology Alliance, previews his session at CPC + CBEx in October on market dynamics that are affecting the implementation of value-based cancer care.
Frederick Schnell, MD, FACP,...
09/18/2023
Journal of Clinical Pathways
James Hamrick Teaser Thumbnail
Videos
09/08/2023
In this video, James Hamrick, MD, MPH, Flatiron Health, previews his session at CPC + CBEx in October on the importance of precision medicine in delivering equitable cancer care.
In this video, James Hamrick, MD, MPH, Flatiron Health, previews his session at CPC + CBEx in October on the importance of precision medicine in delivering equitable cancer care.
In this video, James Hamrick,...
09/08/2023
Cancer Care Business Exchange
John Hennessy Headshot
Videos
08/28/2023
John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
John Hennessy, MBA, Valuate...
08/28/2023
Cancer Care Business Exchange

Advertisement

Cancer Care At Home
Videos
08/18/2023
CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
CBEx Advisory Board Member John...
08/18/2023
Cancer Care Business Exchange
Stop-Loss Insurance, Explained Thumbnail
Videos
08/07/2023
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate...
08/07/2023
Cancer Care Business Exchange
Health Care Sharing Plans, Explained Thumbnail
Videos
07/25/2023
John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.
John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.
John Hennessy, MBA, Valuate...
07/25/2023
Cancer Care Business Exchange

Advertisement

Thomas Stricker, MD.
Videos
07/12/2023
Thomas Stricker, MD, PhD, speaks with the Journal of Clinical Pathways about his research on the clinical impact of the timing of first line targeted therapy in aNSCLC patients with actionable driver oncogenes.
Thomas Stricker, MD, PhD, speaks with the Journal of Clinical Pathways about his research on the clinical impact of the timing of first line targeted therapy in aNSCLC patients with actionable driver oncogenes.
Thomas Stricker, MD, PhD, speaks...
07/12/2023
Journal of Clinical Pathways
Janet Espirito, PharmD.
Videos
07/03/2023
Janet L. Espirito, PharmD, Senior Medical Director for Ontada, speaks with the Journal of Clinical Pathways about the significance of her research on real-world response endpoints in patients with mNSCLC treated with chemotherapy across...
Janet L. Espirito, PharmD, Senior Medical Director for Ontada, speaks with the Journal of Clinical Pathways about the significance of her research on real-world response endpoints in patients with mNSCLC treated with chemotherapy across...
Janet L. Espirito, PharmD,...
07/03/2023
Journal of Clinical Pathways
CBEX EOM video thumbnail.
Videos
06/14/2023
Ron Barkley, MS, JD, from the Cancer Center Business Development Group, speaks with Marissa Rivera, MBA, Ventura County Hematology Oncology Specialists; Alexandra Chong, PhD, Center for Medicare & Medicaid Innovation; Barry Russo, MBA,...
Ron Barkley, MS, JD, from the Cancer Center Business Development Group, speaks with Marissa Rivera, MBA, Ventura County Hematology Oncology Specialists; Alexandra Chong, PhD, Center for Medicare & Medicaid Innovation; Barry Russo, MBA,...
Ron Barkley, MS, JD, from the...
06/14/2023
Cancer Care Business Exchange

Advertisement

Advertisement